Deep Genomics Inc
Deep Genomics Inc., based in Toronto, is at the forefront of revolutionizing drug development through the integration of artificial intelligence and RNA biology. Their proprietary AI platform enables the identification of novel therapeutic targets and the programming of RNA therapies for a wide range of genetic conditions.
Since unlocking their first targets in 2018, Deep Genomics has continued to expand its capabilities, including the development of Big RNA, which aims to tackle more complex genetic diseases. The company is dedicated to harnessing data-driven predictions to accelerate the discovery of valuable medicines and address the genetic challenges faced by individuals worldwide.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.
